![]() |
市場調查報告書
商品編碼
1846086
2024 年至 2031 年吹灌封技術市場(按產品類型、材料類型、最終用戶產業和地區分類)Blow-Fill-Seal Technology Market by Product Type (Bottles, Vials, Ampoules, Pre-filled Syringes & Injectables), Material Type (Polypropylene, Polyethylene), End-User Industry (Pharmaceutical, Food & Beverages), & Region for 2024- 2031 |
||||||
製藥業對無菌安全包裝的需求日益成長,是吹灌封 (BFS) 技術市場的主要驅動力。該技術將吹瓶、填充和封口操作整合到一個自動化系統中,提高了生產效率,同時減少了污染問題,解決了製藥和食品行業面臨的重大藥物輸送和包裝挑戰。根據 Verified Market Research 分析師預測,到 2024 年,吹灌封技術市場規模預計將下降至約 603.5 億美元,預測期內估值將達到 2,956.1 億美元。
慢性病的增加以及隨之而來的對注射藥物的需求、對患者安全和依從性的日益關注是推動吹灌封 (BFS) 技術市場發展的關鍵因素,預計 2024 年至 2031 年的複合年成長率將達到 21.97%。
吹灌封技術市場定義/概述
吹-灌-封 (BFS) 技術是一種用於無菌液體產品包裝的自動化生產流程,可連續成型、填充和密封塑膠容器。此工藝主要包含三個步驟:將熱塑性塑膠管吹製成所需的容器形狀、將產品填充其中以及進行密封以保持無菌和產品完整性。由於 BFS 技術具有降低污染風險、降低生產成本和延長保存期限等優勢,因此在製藥業中被廣泛用於包裝各種產品,包括注射、疫苗、眼藥水和其他無菌液體製劑。
製藥業是吹灌封 (BFS) 技術市場的主要驅動力。根據美國食品藥物管理局 (FDA) 的報告,2023 年新藥認證將年增 13%,其中許多新藥將需要無菌包裝解決方案。 BFS 技術非常適合滿足這一日益成長的需求,因為它可以生產無菌的單劑量容器。
永續性正成為包裝決策中的重要考量。根據《歐洲塑膠公約》,BFS 技術與標準包裝方法相比,可節省高達 40% 的塑膠。這與歐盟在 2030 年實現所有塑膠包裝可回收或重複使用的目標一致。
此外,食品和飲料行業也擴大使用BFS技術來包裝單份產品。全球食品安全舉措(GFSI) 報告稱,從2020年到2023年,包括BFS在內的無菌包裝技術在食品生產中的使用將增加22%。這一趨勢的驅動力在於人們對更長保存期限和更高食品安全性的追求。
生物基預處理(BFS)設備和機械的高昂前期成本對新參與企業和中小企業採用該技術構成了重大障礙。生物基預處理系統非常複雜,需要大量的資本投入,這限制了市場擴張,尤其是在資金籌措困難的低度開發國家。
此外,BFS技術最適合包裝液體和半液體物料,這限制了其在更大包裝需求中的應用。這項限制可能會限制BFS系統在固態和粉末製劑常見的行業和應用中的使用,從而阻礙整體市場的擴張。
The growing need for sterile and safe packaging options in the pharmaceutical industry is the main driver of the blow-fill-seal (BFS) technology market. This technology combines the blowing, filling, and sealing operations into a single automated system, increasing production efficiency while reducing contamination concerns, thereby addressing significant difficulties in drug delivery and packaging for both the pharmaceutical and food industries. According to the analyst from Verified Market Research, the blow-fill-seal technology market is estimated to reach a valuation of USD 295.61 Billion over the forecast subjugating around USD 60.35 Billion valued in 2024.
The rising prevalence of chronic diseases and the resulting need for injectable drugs, combined with a growing emphasis on patient safety and compliance, are key factors propelling the blow-fill-seal (BFS) technology market forward. It enables the market to grow at a CAGR of 21.97% from 2024 to 2031.
Blow-Fill-Seal Technology Market: Definition/Overview
Blow-Fill-Seal (BFS) technology is an automated manufacturing technique for aseptic liquid product packaging that involves continuously forming, filling, and sealing plastic containers. This technology consists of three major steps: blowing a thermoplastic tube into the required container shape, filling it with the product, and hermetically sealing it to maintain sterility and product integrity. BFS technology is widely used in the pharmaceutical industry to package a variety of products, including injectable medications, vaccines, ophthalmic solutions, and other sterile liquid formulations, due to its benefits in reducing contamination risks, lowering production costs, and increasing shelf life.
The pharmaceutical industry is a key driver of the blow-fill-seal (BFS) technology market. According to an FDA report, new medicine approvals increased by 13% in 2023 compared to the previous year, with many requiring sterile packaging solutions. The BFS technology's capacity to manufacture sterile, single-dose containers makes it suitable for meeting this expanding need.
Sustainability is becoming an important consideration in packaging decisions. According to the European Plastics Pact, BFS technology can save up to 40% more plastic than standard packaging methods. This coincides with the European Union's goal of making all plastic packaging recyclable or reused by 2030.
Furthermore, the food and beverage industry is increasingly using BFS technology to package single-serve items. The Global Food Safety Initiative (GFSI) reported a 22% rise in the usage of aseptic packaging techniques, including BFS, in the food business between 2020 and 2023. This trend is driven by the desire for longer shelf life and higher food safety.
The high initial costs involved with BFS gear and equipment create a substantial barrier for new entrants and smaller businesses seeking to implement this technology. The complexity of BFS systems necessitates significant capital expenditure, limiting market expansion, particularly in underdeveloped countries with limited access to funding.
Furthermore, the BFS technology is best suited for packaging liquid and semi-liquid materials, which limits its application to larger packaging requirements. This constraint limits the use of BFS systems in industries or applications where solid or powdered formulations are more common, potentially impeding overall market expansion.
According to VMR analyst, the bottle segment is anticipated to dominate the segment within the blow-fill-seal technology market during the forecast period. BFS technology enables the production of bottles in a variety of sizes and forms, meeting the unique packaging needs of industries such as medicines, food, and cosmetics. This adaptability helps producers to address specific product requirements while also improving consumer convenience.
Bottles are commonly used to package liquid drugs such as eye drops, nasal sprays, and oral solutions. The growing need for sterile packaging solutions in the pharmaceutical industry is a major driver of the growth of the bottles segment in the BFS technology market.
Furthermore, ongoing research and development activities are aimed at increasing machine efficiency, optimizing packaging designs, and discovering novel materials that are compatible with BFS technology. These advances are projected to improve the capabilities and usage of BFS bottles, accelerating segment growth in the next years.
The pharmaceutical segment is estimated to hold the largest share of the blow-fill-seal technology market during the forecast period. The pharmaceutical industry is experiencing an increase in demand for sterile packaging solutions as injectable medications and biologics become more common. BFS technology provides an effective means for making containers that reduce contamination risks, ensure product safety, and comply with high regulatory criteria, resulting in its widespread application in this market.
The fast growth of biologics and injectable drugs is a major driver in the pharmaceutical BFS market. Because these treatments require particular packaging to retain their efficacy and sterility, BFS technology offers a suitable solution by combining the processes of container construction, filling, and sealing, catering precisely to the needs of these sensitive formulations.
Furthermore, patient safety and medication adherence are becoming increasingly important in the healthcare business. This approach is supported by BFS technology, which allows for the creation of single-dose containers that improve dosage accuracy and lower the risk of contamination, resulting in better patient outcomes and increased demand in the pharmaceutical market.
North America is estimated to exhibit substantial growth during the forecast period. From 2020 to 2023, the United States Food and Medicine Administration (FDA) reported a 15% rise in medicine recalls owing to packaging concerns. This has resulted in a wider use of BFS technology in North America, as it reduces the danger of contamination while improving product integrity. The FDA also reported that BFS-packaged products had 30% fewer recalls than standard packaging methods during the same period.
The North American biopharmaceutical market has been rapidly expanding. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), the United States alone has over 800 biologics in development as of 2023, representing a 25% increase from 2020. These sensitive items require aseptic packing, which BFS technology excels at.
Furthermore, the North American healthcare system is moving toward unit-dose packaging to increase patient safety and prevent pharmaceutical mistakes. According to the American Society of Health-System Pharmacists (ASHP), the percentage of hospitals that use unit-dose systems has climbed from 68% in 2020 to 83% in 2023. BFS technology is suited for making such single-dose containers, which has fueled its development in the region.
The Asia Pacific is estimated to dominate the blow-fill-seal technology market during the forecast period. The Asia Pacific pharmaceutical market has been rapidly expanding. According to an International Trade Administration estimate, the pharmaceutical industry in Asia Pacific was valued at USD 365 Billion in 2022, with a compound annual growth rate (CAGR) of 8.4% through 2027. This increase is fueling demand for innovative packaging technologies such as Blow-Fill-Seal.
Many Asian countries are boosting healthcare spending and launching programs to improve healthcare infrastructure. The World Health Organization reported that healthcare spending in Southeast Asia climbed from 3.5% of GDP in 2010 to 4.9% in 2023. This increasing investment is accelerating the implementation of new medical technology, such as BFS for pharmaceutical packaging.
Furthermore, with increasing concerns about product safety and contamination, there is a greater demand for sterile packaging solutions. From 2020 to 2023, the China Food and Drug Administration reported a 30% growth in the deployment of aseptic packaging technologies, including BFS, in the pharmaceutical and healthcare sectors. This trend is especially prevalent in nations with substantial generic medicine manufacturing sectors, such as India and China.
The competitive landscape of the blow-fill-seal (BFS) technology market is characterized by fierce competition among multiple domestic and international competitors vying for market dominance in a constantly expanding sector. Companies are increasingly relying on strategic activities like mergers, acquisitions, and partnerships to improve their technology skills and broaden their product offerings.
Some of the prominent players operating in the blow-fill-seal technology market include:
Syntegon Technology GmbH
Bosch Packaging Technology GmbH
Buhl France SAS
IWK Verpackungstechnik GmbH
Marchesini Group S.p.A.
Romaco Holding GmbH
Nissei ASB Machine Co., Ltd.
Vetter Pharma International GmbH
Bausch + Strobel Maschinenbau GmbH
Optima Machinery GmbH
In December 2021, Woodstock received a US patent for their Cold BFS system. This technique regulates temperature to prevent heat damage, making it excellent for heat-sensitive pharmaceuticals.
In January 2021, Berry Global Healthcare introduced Cyrano, their lightest blow-fill seal closure. It aims to reduce plastic waste and offer a simple solution for all intravenous and infusion systems.
Blow-Fill-Seal Technology Market, by Category
Product Type:
Bottles
Vials
Ampoules
Pre-filled Syringes & Injectables
Material Type:
Polypropylene
Polyethylene
End-User Industry:
Pharmaceutical
Food & Beverages
Others
Region:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa